BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11836425)

  • 1. Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins.
    Bellows DS; Howell M; Pearson C; Hazlewood SA; Hardwick JM
    J Virol; 2002 Mar; 76(5):2469-79. PubMed ID: 11836425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.
    Bellows DS; Chau BN; Lee P; Lazebnik Y; Burns WH; Hardwick JM
    J Virol; 2000 Jun; 74(11):5024-31. PubMed ID: 10799576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak.
    Marshall WL; Yim C; Gustafson E; Graf T; Sage DR; Hanify K; Williams L; Fingeroth J; Finberg RW
    J Virol; 1999 Jun; 73(6):5181-5. PubMed ID: 10233985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates.
    Khanim F; Dawson C; Meseda CA; Dawson J; Mackett M; Young LS
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2987-99. PubMed ID: 9367386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OTUD1 enhances gastric cancer aggressiveness by deubiquitinating EBV-encoded protein BALF1 to stabilize the apoptosis inhibitor Bcl-2.
    Lin H; Han Y; Sang Y; Wu Y; Tian M; Chen X; Lin X; Lin X
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167132. PubMed ID: 38565386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1.
    Matsuda G; Nakajima K; Kawaguchi Y; Yamanashi Y; Hirai K
    Microbiol Immunol; 2003; 47(1):91-9. PubMed ID: 12636258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak.
    Cheng EH; Nicholas J; Bellows DS; Hayward GS; Guo HG; Reitz MS; Hardwick JM
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):690-4. PubMed ID: 9012846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus gene BHRF1, a homologue of the cellular oncogene Bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs.
    McCarthy NJ; Hazlewood SA; Huen DS; Rickinson AB; Williams GT
    Adv Exp Med Biol; 1996; 406():83-97. PubMed ID: 8910674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpesvirus pan encodes a functional homologue of BHRF1, the Epstein-Barr virus v-Bcl-2.
    Howell M; Williams T; Hazlewood SA
    BMC Microbiol; 2005 Feb; 5():6. PubMed ID: 15691372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival.
    Li LY; Liu MY; Shih HM; Tsai CH; Chen JY
    J Gen Virol; 2006 Oct; 87(Pt 10):2869-2878. PubMed ID: 16963744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2.
    Huang Q; Petros AM; Virgin HW; Fesik SW; Olejniczak ET
    J Mol Biol; 2003 Oct; 332(5):1123-30. PubMed ID: 14499614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death.
    Henderson S; Huen D; Rowe M; Dawson C; Johnson G; Rickinson A
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8479-83. PubMed ID: 8397406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells.
    Dawson CW; Dawson J; Jones R; Ward K; Young LS
    J Virol; 1998 Nov; 72(11):9016-24. PubMed ID: 9765446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesvirus papio encodes a functional homologue of the Epstein-Barr virus apoptosis suppressor, BHRF1.
    Meseda CA; Arrand JR; Mackett M
    J Gen Virol; 2000 Jul; 81(Pt 7):1801-5. PubMed ID: 10859386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for Epstein-Barr viral BALF1 in facilitating tumor formation and metastasis potential.
    Hsu WL; Chung PJ; Tsai MH; Chang CL; Liang CL
    Virus Res; 2012 Feb; 163(2):617-27. PubMed ID: 22230317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.
    Boyd JM; Gallo GJ; Elangovan B; Houghton AB; Malstrom S; Avery BJ; Ebb RG; Subramanian T; Chittenden T; Lutz RJ
    Oncogene; 1995 Nov; 11(9):1921-8. PubMed ID: 7478623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
    Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
    J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus Encoded BCL2, BHRF1, Downregulates Autophagy by Noncanonical Binding of BECN1.
    Wyatt S; Glover K; Dasanna S; Lewison M; González-García M; Colbert CL; Sinha SC
    Biochemistry; 2023 Oct; 62(20):2934-2951. PubMed ID: 37776275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
    Fitzsimmons L; Cartlidge R; Chang C; Sejic N; Galbraith LCA; Suraweera CD; Croom-Carter D; Dewson G; Tierney RJ; Bell AI; Shannon-Lowe C; Herold MJ; Rickinson AB; Colman PM; Huang DCS; Strasser A; Kvansakul M; Rowe M; Kelly GL
    Cell Death Differ; 2020 May; 27(5):1554-1568. PubMed ID: 31645677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.